Robert Hill

Chief Executive Officer at TAE Life Sciences LLC

Health Technology

Consumer Services

Electronic Technology

Active connections

Name	Gender	Age	Linked companies	Collaboration
Jesse Chew	M	43	ACCURAY INCORPORATED	10 years
Joseph Whitters	M	66	ACCURAY INCORPORATED	6 years
Beverly A. Huss	F	64	ACCURAY INCORPORATED	6 years
Bruce Bauer	M	-	TAE Life Sciences LLC TAE Life Sciences LLC Pharmaceuticals: MajorHealth Technology TAE Life Sciences LLC is a privately-held biotechnology company that is developing a new biologically-targeted radiation therapy based on boron neutron capture therapy (BNCT). The company is based in Foothill Ranch, CA. The company is committed to developing next-generation targeted boron drugs and a low-energy accelerator-based neutron source that can treat patients with the most aggressive and recurrent cancers. TAE Life Sciences' Alphabeam™ neutron system and targeted boron drugs are currently in development and have not been approved for sale. Robert W. Hill has been the CEO of the company since 2019.	-
Stuart Peterson	M	-	TAE Life Sciences LLC TAE Life Sciences LLC Pharmaceuticals: MajorHealth Technology TAE Life Sciences LLC is a privately-held biotechnology company that is developing a new biologically-targeted radiation therapy based on boron neutron capture therapy (BNCT). The company is based in Foothill Ranch, CA. The company is committed to developing next-generation targeted boron drugs and a low-energy accelerator-based neutron source that can treat patients with the most aggressive and recurrent cancers. TAE Life Sciences' Alphabeam™ neutron system and targeted boron drugs are currently in development and have not been approved for sale. Robert W. Hill has been the CEO of the company since 2019.	-
Michl Binderbauer	M	-	TAE Life Sciences LLC TAE Life Sciences LLC Pharmaceuticals: MajorHealth Technology TAE Life Sciences LLC is a privately-held biotechnology company that is developing a new biologically-targeted radiation therapy based on boron neutron capture therapy (BNCT). The company is based in Foothill Ranch, CA. The company is committed to developing next-generation targeted boron drugs and a low-energy accelerator-based neutron source that can treat patients with the most aggressive and recurrent cancers. TAE Life Sciences' Alphabeam™ neutron system and targeted boron drugs are currently in development and have not been approved for sale. Robert W. Hill has been the CEO of the company since 2019.	-
Patrick Spine	M	61	ACCURAY INCORPORATED	6 years
Beth Kaplan	F	-	ACCURAY INCORPORATED	10 years
Artem Smirnov	M	-	TAE Life Sciences LLC TAE Life Sciences LLC Pharmaceuticals: MajorHealth Technology TAE Life Sciences LLC is a privately-held biotechnology company that is developing a new biologically-targeted radiation therapy based on boron neutron capture therapy (BNCT). The company is based in Foothill Ranch, CA. The company is committed to developing next-generation targeted boron drugs and a low-energy accelerator-based neutron source that can treat patients with the most aggressive and recurrent cancers. TAE Life Sciences' Alphabeam™ neutron system and targeted boron drugs are currently in development and have not been approved for sale. Robert W. Hill has been the CEO of the company since 2019.	-

Connections Chart

Multi-company connection

Former connections

Name	Gender	Age	Linked companies	Collaboration
Andrew Kirkpatrick	M	61	ACCURAY INCORPORATED	12 years
Madelyn Homick	F	-	ACCURAY INCORPORATED	-
Alaleh Nouri	F	45	ACCURAY INCORPORATED	8 years
Darren J. Milliken	M	53	ACCURAY INCORPORATED	10 years
Louis Lavigne	M	75	ACCURAY INCORPORATED	12 years
Joshua H. Levine	M	66	ACCURAY INCORPORATED	10 years
Jack Goldstein	M	77	ACCURAY INCORPORATED	10 years
Euan Stuart Thomson	M	60	ACCURAY INCORPORATED	10 years
Jennifer Maggio	F	-	ACCURAY INCORPORATED	5 years
Robert Weiss	M	77	ACCURAY INCORPORATED	12 years
Kelly Londy	F	58	ACCURAY INCORPORATED	6 years
Darl S. Moreland	M	65	ACCURAY INCORPORATED	-
Shigeyuki Hamamatsu	M	51	ACCURAY INCORPORATED	4 years
Wayne Wu	M	61	ACCURAY INCORPORATED	12 years
John R. Adler	M	70	ACCURAY INCORPORATED	19 years
Emad Rizk	M	60	ACCURAY INCORPORATED	3 years
Steven J. Anheier	M	-	ACCURAY INCORPORATED	2 years
Derek A. Bertocci	M	70	ACCURAY INCORPORATED	4 years
Gregory E. Lichtwardt	M	69	ACCURAY INCORPORATED	2 years
Dennis L. Winger	M	77	ACCURAY INCORPORATED	8 years
Elizabeth Dávila	F	80	ACCURAY INCORPORATED	15 years
Richard R. Pettingill	M	76	ACCURAY INCORPORATED	10 years
Omar Dawood	M	-	ACCURAY INCORPORATED	7 years
Andrew DeLao	M	49	ACCURAY INCORPORATED	-
Robert Ragusa	M	64	ACCURAY INCORPORATED	3 years
Stan Gee	M	-	ACCURAY INCORPORATED	-
Lionel Hadjadjeba	M	-	ACCURAY INCORPORATED	7 years
John McKune	M	-	ACCURAY INCORPORATED	3 years
Justin Hall	M	46	ACCURAY INCORPORATED	7 years
Anja Kleber	F	-	ACCURAY INCORPORATED	7 years
Ole Steve Mikkelsen	M	-	ACCURAY INCORPORATED	4 years
Christopher D. Mitchell	M	62	ACCURAY INCORPORATED	1 years
Peter Fine	M	72	ACCURAY INCORPORATED	1 years
Mark Hair	M	54	ACCURAY INCORPORATED	-
Robert McNamara	M	67	ACCURAY INCORPORATED	4 years
Theresa L. Dadone	F	70	ACCURAY INCORPORATED	-
Doug Keare	M	-	ACCURAY INCORPORATED	5 years
Jack Wareham	M	81	ACCURAY INCORPORATED	2 years
Vittorio Puppo	M	-	ACCURAY INCORPORATED	-
Kevin Waters	M	46	ACCURAY INCORPORATED	5 years
Holly Rebbeca Grey	F	51	ACCURAY INCORPORATED	-
Wade B. Hampton	M	69	ACCURAY INCORPORATED	3 years
Chris A. Raanes	M	58	ACCURAY INCORPORATED	10 years
Li Yu	M	83	ACCURAY INCORPORATED	6 years
Eric P. Lindquist	M	64	ACCURAY INCORPORATED	6 years
Eric Pauwels	M	63	ACCURAY INCORPORATED	-

Statistics

Country	Connections	% of total
United States	55	100.00%

Age of Connections

Active

Past

Male

Female

Members of the board

Executives

Origin of connections